Other Articles
April 15, 1961

Eaton Agent Pneumonia

Author Affiliations

U. S. Navy; U. S. Naval Reserve; U. S. Naval Reserve; U. S. Naval Reserve

Department of Navy, Bureau of Medicine and Surgery, Research Division, Washington, D. C. (Captain Kingston and Mr. Hellman); Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases, Bethesda, Md. (Dr. Chanock, Mr. James, and Mr. Fox); Naval Medical Field Research Laboratory, Camp Lejeune, N. C. (Lieutenant Mufson); and United States Naval Hospital, Beaufort, S. C. (Lieutenant Manko and Captain Boyers).

JAMA. 1961;176(2):118-123. doi:10.1001/jama.1961.03040150034009

The efficacy of demethylchlortetracycline in primary atypical pneumonia associated with Eaton agent was studied by a double-blind procedure. By a process of randomization, 290 bacteriologically negative patients with pneumonia were distributed between a test series who received 0.9 gm. of the drug per day for 6 days and a contratest series who received a placebo. The two series were comparable as to duration and severity of the illness when the patients were admitted to the study. The drug significantly reduced the duration of fever, rales, cough, and fatigue in Eaton pneumonia. It stopped the progression and accelerated the clearing of pulmonary infection.